Elevation of plasma soluble T cell costimulatory molecules CTLA-4, CD28 and CD80 in children with allergic asthma

International Archives of Allergy and Immunology

Volumn 137, Issue 1, 2005, Pages 45-52

  Ip, W K ^a   Wong, C K ^a   Leung, T F ^a   Lam, C W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Allergic asthma; CD28; CD80; CD86; CTLA 4

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CORTICOSTEROID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN E; CD86 PROTEIN, HUMAN; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ASTHMA; BLOOD; FORCED EXPIRATORY VOLUME; IMMUNOLOGY; NONPARAMETRIC TEST; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; MALE; MEMBRANE GLYCOPROTEINS; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES;

EID: 19444366800     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084612     Document Type: Article

References (46)

1. Stone KD: Atopic diseases of childhood. Curr Opin Pediatr 2003;15:495-511.
2. Yssel H, Groux H: Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int Arch Allergy Immunol 2000;121:10-18.
3. Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-507.
4. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-480.
5. Bretscher P: The two-signal model of lymphocyte activation twenty-one years later. Immunol Today 1992;13:74-76.
6. Gmunder H, Lesslauer W: A 45-kDa human T-cell membrane glycoprotein functions in the regulation of cell proliferative responses. Eur J Biochem 1984;142:153-160.
7. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA: CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405-413.
8. Linsley PS, Clark EA, Ledbetter JA: T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990;87:5031-5035.
9. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, Nadler LM: Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;262:909-911.
10. Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, Golstein P: A new member of the immunoglobulin superfamily - CTLA-4. Nature 1987;328:267-270.
11. Walunas TL, Bakker CY, Bluestone JA: CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996;183:2541-2550.
12. Green JM: The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease. Am J Respir Cell Mol Biol 2000;22:261-264.
13. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R: Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994;1:793-801.
14. Van Neerven RJ, Van de Pol MM, Van der Zee JS, Stiekema FE, De Boer M, Kapsenberg ML: Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy 1998;28:808-816.
15. Tsuyuki S, Tsuyuki J, Einsle K, Kopf M, Coyle AJ: Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 1997;185:1671-1679.
16. Burr JS, Kimzey SL, Randolph DR, Green JM: CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. Am J Respir Cell Mol Biol 2001;24:563-568.
17. Sayegh MH: Finally, CTLA4Ig graduates to the clinic. J Clin Invest 1999;103:1223-1225.
18. Larche M, Till SJ, Haselden BM, North J, Barkans J, Corrigan CJ, Kay AB, Robinson DS: Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol 1998;161:6375-6382.
19. Jaffar Z, Roberts K, Pandit A, Linsley P, Djukanovic R, Holgate S: B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation. Am J Respir Cell Mol Biol 1999;20:153-162.
20. Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ, Tector AJ: A native soluble form of CTLA-4. Cell Immunol 2000;201:144-153.
21. Liu MF, Wang CR, Chen PC, Fung LL: Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecules in patients with systemic lupus erythematosus. Scand J Immunol 2003;57:568-572.
22. Hebbar M, Jeannin P, Magistrelli G, Hatron PY, Hachulla E, Devulder B, Bonnefoy JY, Delneste Y: Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis. Clin Exp Immunol 2004;136: 388-392.
23. McHugh RS, Ratnoff WD, Gilmartin R, Sell KW, Selvaraj P: Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1. Clin Immunol Immunopathol 1998;87:50-59.
24. Hock BD, Patton WN, Budhia S, Mannari D, Roberts P, McKenzie JL: Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients. Leukemia 2002;16:865-873.
25. Jeannin P, Magistrelli G, Aubry JP, Caron G, Gauchat JF, Renno T, Herbault N, Goetsch L, Blaecke A, Dietrich PY, Bonnefoy JY, Delneste Y: Soluble CD86 is a costimulatory molecule for human T lymphocytes. Immunity 2000;13:303-312.
26. Faas SJ, Giannoni MA, Mickle AP, Kiesecker CL, Reed DJ, Wu D, Fodor WL, Mueller JP, Matis LA, Rother RP: Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1. J Immunol 2000;164:6340-6348.
27. Kuiper HM, Brouwer M, Linsley PS, van Lier RA: Activated T cells can induce high levels of CTLA-4 expression on B cells. J Immunol 1995;155:1776-1783.
28. Wang XB, Giscombe R, Yan Z, Heiden T, Xu D, Lefvert AK: Expression of CTLA-4 by human monocytes. Scand J Immunol 2002;55:53-60.
29. Sato S, Fujimoto M, Hasegawa M, Komura K, Yanaba K, Hayakawa I, Matsushita T, Takehara K: Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology 2004;43:1261-1266.
30. Hock BD, McKenzie JL, Patton WN, Haring LF, Yang Y, Shen Y, Estey EH, Albitar M: The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer 2003;98:1681-1688.
31. American Thoracic Society: Medical section of the American Lung Association. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
32. National Institutes of Health, National Heart Lung and Blood Institute. Global initiative for asthma. Bethesda: NHLBI; 1998, Publ No 96-3659B.
33. American Thoracic Society: Standardization of spirometry, 1994. Am J Respir Crit Care Med 1995;152:1107-1136.
34. Lam KK, Pang SC, Allan WG, Hill LE, Snell NJ, Fayers PM, et al: Predictive normograms for forced expiratory volume, forced vital capacity, and peak expiratory flow rate, in Chinese adults and children. Br J Dis Chest 1983;77:390-396.
35. Rosa-Rosa L, Zimmermann N, Bernstein JA, Rothenberg ME, Khurana-Hershey GK: The R576 IL-4 receptor α allele correlates with asthma severity. J Allergy Clin Immunol 1999; 104:1008-1014.
36. Kon OM, Kay AB: T cells and chronic asthma. Int Arch Allergy Immunol 1999;118:133-135.
37. Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, Bousquet J: Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med. 1998;157:403-409.
38. Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, Lam CW: Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001;125:177-183.
39. Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat JF, Bonnefoy JY, Delneste Y: A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 1999;29:3596-3602.
40. Lee SY, Lee YH, Shin C, Shim JJ, Kang KH, Yoo SH, In KH: Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002;122:171-176.
41. Yang KD, Liu CA, Chang JC, Chuang H, Ou CY, Hsu TY, Wang CL: Polymorphism of the immune-braking gene CTLA-4 (+49) involved in gender discrepancy of serum total IgE levels and allergic diseases. Clin Exp Allergy 2004;34:32-37.
42. Djukanovic R: The role of co-stimulation in airway inflammation. Clin Exp Allergy 2000; 30:46-50.
43. Balbo P, Silvestri M, Rossi GA, Crimi E, Burastero SE: Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma. Clin Exp Allergy 2001;31:625-636.
44. Hofer MF, Jirapongsananuruk O, Trumble AE, Leung DY: Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol 1998;101:96-102.
45. Leung TF, Wong CK, Chan IH, Ip WK, Lam CW, Wong GW: Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma. J Allergy Clin Immunol 2002;110:404-409.
46. Giorelli M, Livrea P, Defazio G, Ricchiuti F, Pagano E, Trojano M: IFN-beta1 a modulates the expression of CTLA-4 and CD28 splice variants in human mononuclear cells: Induction of soluble isoforms. J Interferon Cytokine Res 2001;21:809-812.